ArticleClinical and translational medicine2021

CCL4-mediated targeting of spleen tyrosine kinase (Syk) inhibitor using nanoparticles alleviates inflammatory bowel disease.

Wenbin Gong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.